varmam therapy for madhanamantharam

varmam therapy for the management of madhanamantharam (simple myopia)- A pilot study - nil

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/06/088117

Enrollment

Registered

2025-06-03

Start date

Unknown

Completion date

Unknown

Last updated

2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H521- Myopia

Interventions

Intervention1: VARMAM THERAPY: varmam therapy will be given thrice /week for 6 months Control Intervention1: not applicable: not applicable

Eligibility

Inclusion criteria

Inclusion criteria: refractive error from -0.25D to -3 D within 10-20 yrs of age ,both male and female will be included in the study .

Exclusion criteria

Exclusion criteria: patient with k/h/o any eye surgery patient with k/c/o pathological myopia, congenital myopia and myopia associated with other ocular disorders

Design outcomes

Secondary

Measure	Time frame
improvement in symptoms by assessing the gradation of symptom and log MAR scaleTimepoint: 6 months	—

Primary

Measure	Time frame
reduction in spherical dioptric power by assessing the refractive powerTimepoint: 24 WEEKS	—

Countries

India

Contacts

Public ContactDR P SAMUNDESWARI

NATIONAL INSTITUTE OF SIDDHA

mdsamuk@gmail.com9445403599

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026